Meyka Pro banner
Certara, Inc.

Certara, Inc. (CERT) Stock Overview

Explore Certara, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CERTNASDAQ
HealthcareMedical - Healthcare Information Services
$8.43
$0.07(0.84%)
U.S. Market opens in 58h 45m

Certara, Inc. (CERT)

Meyka AI Score

Z

Key Financials

Market Cap1.4B
P/E Ratio-19.04
EPS (TTM)$0.40
ROE-0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$8.26
3 Months$4.57
1 Year Target$4.07

CERT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Certara, Inc. (NASDAQ: CERT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Certara, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CERT on the NASDAQ shows an RSI of 62.30, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $4.07 for the NASDAQ listing.

Key metrics behind Certara, Inc.'s NASDAQ-traded stock include a P/E ratio of -19.04 and a market capitalization of 1.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CERT on the NASDAQ.

Price Performance (NASDAQ: CERT)

1-Day Change
-3.44%
5-Day Change
2.06%
1-Month Change
23.07%
3-Month Change
63.06%
6-Month Change
30.50%
Year-to-Date (YTD) Change
-4.31%
1-Year Change
-21.73%
3-Year Change
-47.67%
5-Year Change
-71.27%
All-Time (Max) Change
-77.86%

Contact Information

609 716 7900
4 Radnor Corporate Center, Radnor, PA, 19087

Company Facts

15,460 Employees
IPO DateDec 11, 2020
CountryUS
Actively Trading

Frequently Asked Questions